OXYPuF: Ambulatory Oxgyen Therapy for Pulmonary Fibrosis
Posted by pfc202
1 September 2022
Primary Objective:
- To determine what is the clinical and cost effectiveness of ambulatory oxygen therapy (AOT) in patients with idiopathic pulmonary fibrosis (IPF)
Inclusion Criteria:
- Clinically diagnosed IPF, confirmed by an ILD MDT linked to an NHS specialist commissioned IPF service
- Breathlessness with MRC dyspnoea score ≥2
Click here to Read a Summary of this trial
More information will be available soon. Please check back soon for contact details and full PIS.